Lahr, Walker S.

EditR: A Method to Quantify Base Editing from Sanger Sequencing

Kluesner, M. G., Nedveck, D. A., Lahr, W. S., Garbe, J. R., Abrahante, J. E., Webber, B. R., & Moriarity, B. S. (2018) · The CRISPR Journal

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 565

Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

Webber, B. R., Lonetree, C.-L., Kluesner, M. G., Johnson, M. J., Pomeroy, E. J., Diers, M. D., Lahr, W. S., Draper, G. M., Slipek, N. J., Smeester, B. A., et al. (2019) · Nature Communications

CRISPR and Genetic EngineeringCAR-T cell therapy research

Cited by 232

CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells

Kluesner, M. G., Lahr, W. S., Lonetree, C.-L., Smeester, B. A., Qiu, X., Slipek, N. J., Claudio Vázquez, P. N., Pitzen, S. P., Pomeroy, E. J., Vignes, M. J., et al. (2021) · Nature Communications

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 121

Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing

Wang, M., Krueger, J. B., Gilkey, A. K., Stelljes, E. M., Kluesner, M. G., Pomeroy, E. J., Skeate, J. G., Slipek, N. J., Lahr, W. S., Claudio Vázquez, P. N., et al. (2025) · Journal for ImmunoTherapy of Cancer

CAR-T cell therapy researchCRISPR and Genetic Engineering

Cited by 45

A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes

Laoharawee, K., Johnson, M. J., Lahr, W. S., Sipe, C. J., Kleinboehl, E., Peterson, J. J., Lonetree, C.-L., Bell, J. B., Slipek, N. J., Crane, A. T., et al. (2022) · International Journal of Molecular Sciences

CRISPR and Genetic EngineeringRNA Interference and Gene Delivery

Cited by 7